Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots than embolize to brain.

cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy

CRYO2 image courtesy of AtriCure Inc.

Technology | March 23, 2015

March 23, 2015 — AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (...

News | March 13, 2015

March 13, 2015 — AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (...

News | February 10, 2015 | Dave Fornell

As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict what the next big...

News | October 13, 2014

October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman...

AtriCure AtriClip Flex Atrial Fibrillation Therapies Cardiac Surgery LAA Occlude
Technology | September 26, 2014

September 26, 2014 — AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more...

News | July 22, 2014

July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip ...

atrial fibrillation, LARIAT
Feature | March 24, 2014
March 24, 2014 – Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique...
Watchman, LAA occluder, atrial fibrillation
Feature | December 12, 2013
December 12, 2013 — The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
Feature | November 19, 2013
November 19, 2013 — AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and...
catheters cath lab ep laa occluders baylis medical torflex transseptal sheath
News | November 11, 2013
November 11, 2013 — The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex...
Blog | November 08, 2013

By Dave Fornell, DAIC editor

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular...

LAA occluder, Watchman

Boston Scientific's Watchman LAA occluder device is designed to prevent stroke in patients atrial fibrillation without the need for warfarin therapy.

Feature | November 08, 2013

November 8, 2013 – According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA)...

Videos | November 07, 2013

Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the...

Lariat Suture Device Left Atrial Appendage Occluder Stroke Risk
News | July 15, 2013

July 15, 2013 — Shore University Medical Center is one of only a handful of hospitals in the country offering the...

FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI

The field of interventional cardiology is one of constant change and innovation. The past 10 years have...

Overlay Init